cardiology careers collections past issues search home
     

J Am Coll Cardiol, 2007; 49:687-694, doi:10.1016/j.jacc.2006.08.062 (Published online 25 January 2007).
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow View Investigators and staff participating in CHARMES
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Persson, H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Persson, H.
Related Collections
Right arrowRelated Article

Diastolic Dysfunction in Heart Failure With Preserved Systolic Function: Need for Objective Evidence

Results From the CHARM Echocardiographic Substudy–CHARMES

Hans Persson, MD, PhD*,*, Eva Lonn, MD, MSc{dagger}, Magnus Edner, MD, PhD*, Lawrence Baruch, MD{ddagger}, Chim C. Lang, MD§, John J. Morton, PhD||, Jan Östergren, MD, PhD, Robert S. McKelvie, MD, PhD{dagger} for the Investigators of the CHARM Echocardiographic Substudy–CHARMES

* Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital Department of Cardiology, Stockholm, Sweden
{dagger} Population Health Research Institute and McMaster University, Hamilton, Canada
{ddagger} Bronx Veterans Affairs Medical Center, Mt. Sinai School of Medicine, Bronx, New York
§ Ninewells Hospital and Medical School, Dundee, United Kingdom
|| Western Infirmary, University of Glasgow, Glasgow, United Kingdom
Department of Medicine, Karolinska University Hospital, Solna, Stockholm, Sweden.


Figure 1
View larger version (15K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 Classification of LV Diastolic Function

Left ventricular (LV) diastolic function categorized into 4 groups. 1) Normal: mitral inflow parameters within normal range and normal pulmonary vein flow or normal N-terminal pro-brain natriuretic peptide (NT-proBNP). 2) Abnormal relaxation: a) early filling peak velocity/atrial filling peak velocity (E/A) ratio lower than age-related value and/or b) isovolumic relaxation time/deceleration time (IVRT/DT) longer than age-related value. 3) Pseudonormal: normal mitral inflow parameters and a) elevated NT-proBNP, b) abnormal pulmonary venous flow, or c) abnormal E/A–E/A during Valsalva. 4) Restrictive: a) E/A ratio higher than age-related value and/or b) IVRT/DT shorter than age-related value. Pulmonary venous flow was considered abnormal if any one of the following criteria were present: 1) pulmonary vein systolic/diastolic velocity less than age-related value, 2) pulmonary vein a-duration longer than mitral a-duration, or 3) pulmonary vein peak a-velocity greater than age-related value. Normal values are in Table 1.

 

Figure 2
View larger version (20K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2 CV Death or HF Hospitalization According to Diastolic Function Class

Univariate hazard ratios (95% confidence intervals) for relaxation abnormality versus normal = 1.4 (0.4 to 5.7); pseudonormal versus normal = 4.5 (1.5 to 13.2); and restrictive versus normal = 7.2 (1.8 to 29.0). CV = cardiovascular; HF = heart failure.

 

Figure 3
View larger version (10K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3 CV Death or HF Hospitalization in Group With Pseudonormal Diastolic Function

Univariate hazard ratio (95% confidence intervals) for outcome in patients with pseudonormal diastolic dysfunction characterized by N-terminal pro-brain natriuretic peptide (NT-proBNP) versus Doppler = 0.8 (0.2 to 2.7). Abbreviations as in Figure 2.

 




 
  cardiology careers collections past issues search home